TNFRSF8 and lymphoma: We generated a series of recombinant anti-CD30 antibody-cytokine fusion proteins, each with the same anti-CD30 HRS3 single chain fragment of variable regions (scFv) antibody for targeting CD30+ Hogdkin's lymphoma cells, but with different cytokine domains (Fig. 1).